Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass.

Slides:

Advertisements

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Advertisements

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease Ramon Berguer, MD, PhD, Mark D. Morasch,

Is long vein bypass from groin to ankle a durable procedure

Richard M. Green, MD, William M

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Recurrent thromboembolism in patients with vena cava filters

Ergotism associated with HIV antiviral protease inhibitor therapy

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D.

Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomized study Jean-Pierre.

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia Louis L. Nguyen,

Surgery of popliteal artery aneurysms: A 12-year experience

The percutaneous Greenfield filter: Outcomes and practice patterns

Asymptomatic internal carotid artery aneurysm

Unplanned return to operating room after lower extremity arterial bypass is an independent predictor for hospital readmission Faisal Aziz, MD, FACS,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Carotid-carotid crossover bypass: Is it a durable procedure?

Axillofemoral bypass: A tool with a limited role

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Multilevel data analysis: What? Why? How?

Collateral artery from arteriovenous malformation of the rectum in a patient with peripheral artery disease Hirotomo Uchiyama, MD, Reiji Hattori, MD,

Protecting the brain and spinal cord

Carotid-subclavian bypass grafting with polytetrafluoroethylene grafts for symptomatic subclavian artery stenosis or occlusion: A 20-year experience

Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization Gregory S. Cherr, MD, Jiping Wang, MD,

Axillopopliteal bypass for limb salvage

Infrainguinal revascularizations in octogenarians and septuagenarians

Recurrent thromboembolism in patients with vena cava filters

Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients Mario Monaco, MD, Luigi Di Tommaso, MD,

Peripheral atherectomy with the rotablator: A multicenter report

A prospective randomized trial comparing vein with polytetrafluoroethylene in above- knee femoropopliteal bypass grafting Desiree H.C. Burger, MDa, A.Pieter.

First textbook in vascular surgery

Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal.

Surgical reconstruction of iliofemoral veins and the inferior vena cava for nonmalignant occlusive disease Corey J. Jost, MD, a, Peter Gloviczki, MD,

Infrainguinal arterial reconstruction for claudication: Is it worth the risk? An analysis of 409 procedures John Byrne, MD, R.Clement Darling III, MD,

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Bypass in the absence of ipsilateral greater saphenous vein: Safety and superiority of the contralateral greater saphenous vein David K.W. Chew, MD,

Reviewer Acknowledgment

Ramon Berguer, MD, PhD, Lisa M. Flynn, MD, Ronald A

Javier G. Jimenez, MD, Thomas S. Huber, MD, PhD, C

Ipsilateral femoral vein compression: A contraindication to thrombin injection of femoral pseudoaneurysms Benjamin Hung, MD, a, Bertrand Gallet, MD,

Long-term assessment of cryopreserved vein bypass grafting success

Does surgical correction of the superficial femoral vein valve change the course of varicose disease? Nina Petrovna Makarova, MD, PhD, Fedor Lurie, MD,

Is prosthetic renal artery reconstruction a durable procedure

Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts C.J. Buckley, MD, S. Abernathy,

Composite sequential bypasses to the ankle and beyond for limb salvage

Joseph G. Magnant, MD, Jack L. Cronenwett, MD, Daniel B

Popliteal artery aneurysms

Carlos H. Timaran, MD, Scott L. Stevens, MD, Oscar H

Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy Paul A. Armstrong, DO, Dennis F. Bandyk,

Peripheral vascular bypass in juvenile-onset diabetes mellitus: Are aggressive revascularization attempts justified? Christopher J. Kwolek, MD, Frank.

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

Creating functional autogenous vascular access in older patients

Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: Six-year results of a randomized clinical trial Gijs J. Aalders,

Surgical management of severe acute lower extremity ischemia

Stanley Ziomek, M. D. , William J. Quiñones-Baldrich, M. D. , Ronald W

Seizures following subclavian-carotid bypass

Early experience with cryopreserved saphenous vein allografts as a conduit for complex limb-salvage procedures Philip J. Walker, FRACS, R.Scott Mitchell,

Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass.

Homologous veins as an arterial substitute: Long-term results

Long-term results of arterial allograft below-knee bypass grafts for limb salvage: A retrospective multicenter study J.N. Albertini, MD, X. Barral, MD,

Presidential address: The second-generation vascular surgeon

The Propranolol Aneurysm Trial Investigators

Determinants of successful peroneal artery bypass

Gary A. Tannenbaum, MD, Frank B. Pomposelli, MD, Edward J

Scott A. Berceli, MD, PhD, Allen K. Chan, MD, Frank B

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Innominate artery trauma: A thirty-year experience

Benjamin B. Chang, MD, R. Clement Darling, MD, Devon E. M

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Superficial femoral artery eversion endarterectomy: A useful adjunct for infrainguinal bypass in the presence of limited autogenous vein Spence M. Taylor,

Presentation transcript:

Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: A prospective randomized study Willard C. Johnson, MD a, William O. Williford, PhD bc Journal of Vascular Surgery Volume 35, Issue 3, Pages 413-421 (March 2002) DOI: 10.1067/mva.2002.121847 Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

Fig. 1 Schematic presentation of study participants with loss of bypass patency. ASA, Aspirin therapy. Journal of Vascular Surgery 2002 35, 413-421DOI: (10.1067/mva.2002.121847) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

Fig. 2 Assisted primary patency rates of prosthetic (A) and vein (B) lower extremity arterial bypasses. Journal of Vascular Surgery 2002 35, 413-421DOI: (10.1067/mva.2002.121847) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions

Fig. 3 Patient survival rates with prosthetic (A) and vein bypasses (B). Journal of Vascular Surgery 2002 35, 413-421DOI: (10.1067/mva.2002.121847) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions